Abdominal pain pills

Abdominal pain can have different origins. Therefore, the means to cope with this ailment differ in their characteristics. Tablets for abdominal pain are intended for the treatment of one problem or a complex of interrelated symptoms.

Cutting pains in the navel area may indicate stomach problems or gastritis.

On the right, in the hypochondrium, the gallbladder may hurt due to the presence of stones in it, or the liver may make itself known. Pain on the left, under the ribs, indicates dysfunction of the pancreas, and below in the same area - problems with the duodenum. Abdominal pain with an unspecified localization and the presence of signs of indigestion may indicate problems with the intestines. And pain of a spasmodic nature is caused by spasms of the pelvic muscles. Such pain occurs in women during menstruation. Each of these problems requires its own method of treatment, and, accordingly, the use of certain medications.

Of course, it is important to understand that abdominal pain can be a manifestation of a serious disease that is dangerous to a person's life, such as acute appendicitis. In this case, the pain is localized on the right side below. In pregnant women, abdominal pain can indicate the presence of an ectopic pregnancy that is dangerous to her life. Therefore, self-medication is not worth it, but it is best to seek advice and help from specialists.

Indications for the use of tablets for abdominal pain

Each drug is intended for use in specific cases. Indications for the use of tablets for abdominal pain are printed in the instructions supplied with the medicine, and these instructions must be read before starting to use the medicine.

1. Drotaverine hydrochloride.
   • The presence of smooth muscle spasms related to the biliary tract, which are caused by cholelithiasis, cholangiolithiasis, cholecystitis, periocholecystitis, cholangitis and papillitis.
   • Signs of spasms of smooth muscles present in the urinary tract, and caused by nephrolithiasis, urethrolithiasis, pyelitis, cystitis, and bladder thesmas.
   • It is used as an adjuvant therapy for spasmodic manifestations in the smooth muscles of the stomach and intestines caused by gastric ulcer and duodenal ulcer, gastritis, spasms of the cardia and pylorus, enteritis, colitis, spastic colitis with constipation and flatulent forms of mucous colitis.
2. Duspatalin.
   • It is used for spasms of the gastrointestinal tract, which can also be caused by organic diseases.
   • Used for intestinal and biliary colic.
   • Used for irritable bowel syndrome.
   • For children over twelve years of age, the medication is used for functional disorders of the gastrointestinal tract, which are accompanied by pain in the abdomen.
3. Imodium Plus.
   • The occurrence of diarrhea from any cause of origin.
   • The appearance of accompanying symptoms - flatulence, intestinal gas retention, abdominal discomfort, spastic pain.
4. Loperamide.
   • The appearance of acute and chronic signs of diarrhea of allergic, emotional, medicinal or radiation origin.
   • It is used in the treatment of diarrhea associated with changes in diet and quality of nutrition, with impaired metabolism and absorption processes.
   • It is used as an adjuvant in the treatment of diarrhea of infectious origin.
   • It is used to regulate stool in patients with ipestomas.
5. Maalox.
   • The presence of an exacerbation of gastric ulcer and duodenal ulcer.
   • The appearance of an exacerbation of acute gastroduodenitis and chronic gastroduodenitis, which have normal or increased secretory function.
   • The occurrence of a hernia located in the esophageal opening of the diaphragm, as well as the appearance of reflux esophagitis.
   • The presence of dyspeptic symptoms in the form of discomfort or pain in the epigastrium; the appearance of heartburn, sour belching after nutritional disorders, as well as with excessive consumption of alcohol, coffee drinks and smoking.
   • The occurrence of dyspeptic phenomena in the form of discomfort and pain in the epigastrium, as well as symptoms of heartburn, sour belching, which may occur as a result of the use of certain medications - non-steroidal anti-inflammatory drugs and glucocorticosteroids.
6. Mezim Forte.
   • It is used in replacement therapy, which treats insufficiency of the exocrine function of the pancreas, including chronic pancreatitis and cystic fibrosis.
   • Prescribed for chronic inflammatory-dystrophic gastric, intestinal, liver diseases, as well as similar problems with the gallbladder.
   • These tablets for abdominal pain are used for gastrointestinal disorders that are functional in nature and caused by intestinal diseases of an infectious nature and irritable bowel syndrome.
   • In case of nutritional errors in patients with normal functioning of the gastrointestinal tract.
   • It is used as a therapy for conditions caused by resection or irradiation of the gastrointestinal tract: digestive disorders, flatulence, diarrhea.
7. No-shpa Forte.
   • It is used for smooth muscle spasms caused by diseases of the biliary tract, namely cholecystolithiasis, cholelithiasis, cholecystitis, pericholecystitis, cholangitis, papillitis.
   • It is used for spasms of the smooth muscles of the urinary tract caused by certain diseases, namely, nephrolithiasis, urethrolithiasis, pyelitis, cystitis, and bladder spasms.
   • As an element of adjuvant therapy, it is taken for spasms of the smooth muscles of the gastrointestinal tract caused by gastric ulcer and duodenal ulcer, gastritis, spasms of the cardia and pylorus, enteritis, colitis, spastic colitis with accompanying constipation and irritable bowel syndrome with manifestation of flatulence. The drug should be taken in these cases if diseases characterizing the acute abdomen syndrome are excluded, namely, signs of acute appendicitis, peritonitis, ulcer perforation, acute pancreatitis.
   • Used for tension headaches.
   • It is used for dysmenorrhea accompanied by pain.
8. Festal.
   • The presence of insufficient secretion in the pancreas, which accompanies chronic pancreatitis and is combined with biliary insufficiency, which manifests itself in impaired digestion of food, flatulence, and constipation.
   • It is used as one of the means in the combined treatment of such diseases as diffuse liver diseases associated with alcoholic and toxic liver damage, and liver cirrhosis.
   • It is used as part of complex therapy for the loss of bile acids in large quantities, usually in patients who have undergone cholecystectomy.
   • It is used as one of the medications in combination treatment for impaired circulation of bile acids, which is observed in diseases such as biliary dyskinesia, dysbacteriosis, and malabsorption.
   • It is used for neurohumoral disorders of the processes of bile formation and separation that accompany chronic diseases of the gastrointestinal tract, namely chronic gastritis, chronic duodenitis, chronic cholecystitis.
   • It is used to improve the digestion processes in patients with normal functioning of the gastrointestinal tract. This can happen due to a violation of proper nutrition, as well as problems with the chewing function, prolonged immobilization, and a sedentary lifestyle.
   • Prescribed in preparation for examination of the internal organs of the peritoneum using X-rays and ultrasound diagnostics.
9. Phthalazole.
   • The occurrence of dysentery in an acute form or exacerbation of a chronic form of the disease.
   • The appearance of colitis.
   • The occurrence of gastroenteritis.
   • The need for preventive measures against the occurrence of purulent complications after surgical operations in the intestine.

Release form

Tablets for oral use are the form of release of the drugs described in the article. They differ in color, size, shape and smell, and have or do not have a shell.

• Drotaverine hydrochloride.

It is produced in tablets of forty milligrams of the active component each. The tablets are yellow or yellow with a greenish tint, flat-cylindrical in shape and have a chamfer in the middle. The tablets are placed in a blister pack of ten pieces each and are packaged in cardboard packs of two blister packs, and are also supplied with a leaflet with instructions.

Drotaverine Forte contains eighty milligrams of active substance in each tablet and is available in tablets. The tablets are placed in a blister of ten pieces, two blisters are packed in a cardboard box and supplied with an instruction leaflet.

Each tablet contains forty grams (or eighty grams) of drotaverine hydrochloride, as well as a certain amount of excipients: lactose monohydrate, potato starch, talc, stearic acid.

• Duspatalin.

It is produced in capsules with prolonged action, which are white and have the number 245 on the body, and the Latin letter S and the number 7 on the capsule cap. The capsules are not transparent and are made of hard gelatin. Inside the capsules there are granules of white or almost white color. The capsules are packed in a blister of ten pieces each. Blisters of two or three pieces are placed in a cardboard box and supplied with a leaflet with instructions.

Each capsule contains two hundred milligrams of the active substance - mebeverine hydrochloride, as well as a certain amount of excipients: magnesium stearate, methacrylic acid copolymer, talc, hypromellose, methacrylic and ethacrylic acid copolymer, glycerol triacetate, gelatin, titanium dioxide.

• Imodium Plus.

It is produced in the form of chewable tablets, which are white and have a round flat shape, as well as the inscription IMO on one side of the tablet. They have a vanilla and mint smell.

Each tablet contains the active ingredients loperamide hydrochloride - two milligrams and simethicone - one hundred twenty-five milligrams, as well as a certain amount of auxiliary components: sugar, microcrystalline cellulose, basic polymethacrylate, cellulose acetate, sorbitol, dextrates, vanilla flavoring, sodium saccharin, stearic acid, calcium phosphate.

Packaged in four or twelve tablets per pack.

• Loperamide.

The medicine is produced in the form of hard gelatin capsules No. 3, which have a white body with a green cap. The capsules contain white or white with a yellow tint powder. The capsules weigh two milligrams. The capsules are placed in ten pieces in a blister pack. One or two blister packs are placed in a cardboard box and supplied with an insert with instructions.

One capsule contains the active substance - loperamide hydrochloride - two milligrams, as well as some auxiliary components: lactose monohydrate, potato starch, colloidal silicon dioxide, calcium stearate. The body of the gelatin capsule consists of gelatin and titanium dioxide, and the capsule cap has a composition in the form of gelatin, titanium dioxide, iron oxide yellow dye and indigo carmine.

• Maalox.

It is produced in the form of chewable tablets with sugar and chewable tablets without sugar. Chewable tablets with sugar are white and round, flat-cylindrical. Also on the tablet there is a chamfer and engraving "Mx".

Sugar-free chewable tablets for stomach pain are white or yellowish in colour with some marbling, round and flat-cylindrical in shape. The tablets have a chamfer and engraving "MAALOX" on one side and "sans sucre" on the other. The tablets have a lemon smell.

Chewable tablets with sugar are placed ten pieces per blister, made of aluminum foil or PVC. One, two or four blisters are placed in a cardboard box and supplied with a leaflet with instructions.

Sugar-free chewable tablets are packaged in 10 pieces per blister made of aluminum foil, PVC or PVDC. One, two or four blisters are placed in a cardboard box and accompanied by a leaflet with instructions.

One tablet with sugar contains four hundred milligrams of active substances - magnesium hydroxide and algedrate, as well as a certain amount of auxiliary components: starch with sucrose, sorbitol, mannitol, magnesium stearate, mint flavoring, sodium saccharinate, sucrose.

Sugar-free tablets contain four hundred milligrams of active ingredients - magnesium hydroxide and algeldarate, as well as a certain amount of auxiliary components: liquid sorbitol, maltitol, magnesium stearate, lemon flavoring, flavoring agents, natural flavoring agents, acacia gum, citric acid, butylhydroxyanisole, sodium saccharinate, glycerol, talc.

• Mezim Forte.

It is produced in the form of pink and round tablets, which are covered with an enteric coating. Each tablet has a biconvex surface, a chamfer, and on its fracture you can also see a few brown inclusions.

The tablets are placed ten pieces per blister pack made of aluminum, polyamide or PVC. One or two blisters are placed in a cardboard pack and supplied with an instruction leaflet.

Each tablet has a core and an enteric coating. The core consists of the active substance - pancreatin powder in the amount of one hundred thirty-seven and a half milligrams, which contains lipase - ten thousand units, amylase - seven and a half thousand units, protease - three hundred seventy-five units. Of the auxiliary components there is a certain amount of lactose monohydrate, microcrystalline cellulose, colloidal silicon dioxide, crospovidone, magnesium stearate.

The enteric coating consists of a certain amount of hypromellose, methacrylic acid, ethyl acrylate copolymer, thirty percent dispersion, triethyl citrate, titanium dioxide, talc, thirty percent emulsion simethicone, macrogol 6000, sodium carmellose, polysorbate 80, azorubic varnish, sodium hydroxide.

• No-shpa Forte.

It is produced in tablets of forty milligrams each. The tablet has a round biconvex shape and is yellow in color, with some green or orange tint. On one side of the tablet there is an engraving "spa".

The tablets are packaged in six or twenty-four pieces in one blister made of aluminum or PVC. One blister is placed in a cardboard box and is accompanied by an instruction leaflet.

The tablets can also be packaged in bottles made of polypropylene and equipped with a single-piece dispenser, in the amount of sixty pieces per bottle.

Tablets for abdominal pain are also placed in a polypropylene bottle with one hundred tablets in each and are supplied with a polyethylene stopper.

Each bottle is packed in a cardboard box and supplied with an instruction leaflet.

Each tablet contains the active substance - drotaverine hydrochloride - forty milligrams, as well as a certain amount of auxiliary components: magnesium stearate, talc, corn starch, lactose monohydrate.

• Festal.

The medicine is produced in the form of white, glossy, round dragees, which have a faint vanilla smell. Ten dragees are placed in strips, and the strips are packaged in cardboard packs in quantities of two, four, six or ten pieces, supplied with a leaflet with instructions.

One dragee contains one hundred ninety-two milligrams of the active substance pancreatin, fifty milligrams of the active component hemicellulose and twenty-five milligrams of the active substance bile component. In addition, the dragee contains a certain amount of auxiliary substances: sodium chloride, cellacephate, ethyl vanillin, castor oil, sucrose, methyl parahydroxybenzoate, propylparaben, gelatin, liquid glucose, talc, calcium carbonate, acacia gum, dlicerod, macrogol, titanium dioxide.

• Phthalazole.

The medicine is produced in the form of white or white-yellowish tablets, have a flat-cylindrical shape and a chamfer with a risk. The tablets are packaged in ten pieces in a cell-less blister pack or a blister pack. Two blister packs are placed in a cardboard box and supplied with a leaflet with instructions.

One tablet contains five hundred milligrams of the active ingredient phthalylsulfathiazole and a certain amount of excipients: potato starch, calcium stearate, talc.

[ 1 ], [ 2 ]

Pharmacodynamics of tablets for abdominal pain

The processes that occur in the body after taking the drug are different. Each drug is designed to solve certain problems. The mechanism of action is described in the section pharmacodynamics of tablets for abdominal pain.

• Drotaverine hydrochloride.

It is an isoquinoline derivative that has a spasmolytic effect on smooth muscles. This occurs through the process of inhibiting the enzyme phosphodiesterase 4, which accordingly increases the concentration of cAMP, which then leads to the inactivation of the light chain of myosin kinase, leading to a relaxing effect on smooth muscles.

It is considered an effective drug with an antispasmodic effect, but does not lead to side effects in the cardiovascular system. The drug is used for disorders of nervous regulation and self-regulation, caused by both nervous and muscular nature. The drug has an effect on the smooth muscles located in the gastrointestinal tract, and also has a good effect on the biliary, urogenital and vascular systems. The drug has a vasodilatory effect, which helps improve blood flow in tissues. It has a stronger effect than papaverine, is absorbed better and faster, binds less to blood plasma proteins, and does not have a stimulating effect on the respiratory system.

• Duspatalin.

These tablets for abdominal pain are an antispasmodic agent with a myotropic effect, which acts directly on the smooth muscles of the gastrointestinal tract, and most of all on the large intestine. It leads to the elimination of spasms without affecting the processes of intestinal peristalsis. It does not have an anticholinergic effect.

• Imodium Plus.

The active component of the drug - loperamine hydrochloride - is able to bind to opiate receptors located in the intestinal walls. This action causes inhibition of propulsive peristalsis, increases intestinal transit time and enhances the resorption of water and electrolytes. The substance does not lead to changes in the physiological intestinal microflora, and also helps to increase the tone of the anal sphincter. It does not have a central effect.

Another active ingredient, simethicone, is an inert surfactant that has a defoaming effect. As a result, the symptoms caused by diarrhea are alleviated, as well as the accompanying signs of the disease - flatulence, abdominal discomfort, bloating and cramps.

• Loperamide.

The active component, loperamide, binds to opioid receptors located in the intestinal walls, thereby stimulating cholinergic and adrenergic neurons via guanine nucleotides. This reduces the motility of intestinal smooth muscles, slows down the passage of intestinal contents, and reduces the release of fluids and electrolytes with feces. The tone of the anal sphincter also increases, which leads to better retention of feces and a decrease in the number of urges to empty the bowels.

The action of these tablets for abdominal pain occurs quickly and lasts for four to six hours.

• Maalox.

The medicine neutralizes the hydrochloric acid without causing secondary hypersecretion of this acid. When using the medicine, the acidity level in the stomach increases, which leads to a decrease in the peptic activity of the gastric juice. It has sorbent and ovaling properties, which reduces the impact of factors that damage the mucous membrane.

Mezim Forte.

The drug contains powder made from pig pancreas and contains exocrine pancreatic enzymes - lipase, amylase, protease, trypsin, chymotrypsin, as well as other enzymes.

Pancreatic enzymes facilitate the breakdown of substances such as proteins, fats and carbohydrates, which affects their absorption in the small intestine, making it more complete. Trypsin suppresses the stimulation of enzyme production by the pancreas and has an analgesic effect. The most powerful activity of the drug's enzymes occurs half an hour or forty-five minutes after taking the medicine.

• No-shpa Forte.

The active ingredient of the drug - drotaverine hydrochloride - is an isoquinoline derivative. It has a powerful spasmolytic effect on smooth muscles by inhibiting phosphodiesterase. Phosphodiesterase is necessary for the process of hydrolysis of cyclic adenosine monophosphate to adenosine monophosphate.

It has been established that the drug can inhibit the effectiveness of the phosphodiesterase 4 isoenzyme without exerting a similar effect on phosphodiesterase 3 and 5. The level of drug effectiveness depends on the concentration of phosphodiesterase 4 in tissues. This isoenzyme is important in suppressing the contractility of smooth muscles, which is useful in the treatment of hyperkinetic dyskinesia of various types and other diseases that cause spastic manifestations in the gastrointestinal tract.

It has shown its effectiveness in smooth muscle spasms caused by neurogenic and muscular origin. The active component of the drug is able to relax the smooth muscles of the gastrointestinal tract, biliary tract and genitourinary system, regardless of the type of vegetative innervation.

• Festal.

The drug is able to compensate for the problem of insufficient pancreatic secretion with the help of pancreatin, as well as the function of bile secretion by using the bile component of the drug.

It has proteolytic, amyolytic and lipolytic effects. The action of lipase, amylase, protease - enzymes included in pancreatin, lead to easier digestion of such food components as fats, proteins and carbohydrates. Due to this, these substances are better absorbed in the small intestine.

Bile acids correct biliary insufficiency, which in many cases accompanies chronic pancreatitis. Bile extract leads to increased production of bile in the body, and also improves the absorption of fats and vitamins A, E and K, which are fat-soluble.

The action of the hemicellulose enzyme leads to improved breakdown of plant fiber, which helps improve digestion processes and reduce the formation of intestinal gases.

• Phthalazole.

These stomach pain pills prevent the inclusion of para-aminobenzoic acid in the production of folic acid in the cell of the microorganism. This disrupts the formation of folic acid, which takes part in the production of those substances that affect the growth and development of the microorganism.

The greatest effect is observed on vegetative forms of microbes, developing consistently and gradually.

It has an anti-inflammatory effect, which consists of limiting the spread of leukocytes, which reduces the total number of cellular elements and stimulates the production of glucocorticosteroids.

The drug is effective against streptococci, pneumococci, staphylococci, meningococci, gonococci, Pseudomonas aeruginosa, Escherichia coli, Shigella dysenteriae, Proteus vulgaris and a number of large viruses that cause trachoma and follicular conjunctivitis.

Pharmacokinetics of tablets for abdominal pain

Each drug undergoes transformation in the human body. Familiarization with the section on pharmacokinetics of tablets for abdominal pain will help to understand these mechanisms.

• Drotaverine hydrochloride.

The active component is quickly absorbed from the gastrointestinal tract when taken orally. The half-absorption period is twelve minutes, the bioavailability of the substance is almost one hundred percent. The maximum concentration in the blood plasma is observed from forty-five minutes to one hour.

The active component is unable to penetrate the blood-brain barrier. Metabolic processes with the substance occur in the liver. After seventy-two hours, drotaverine is almost completely excreted from the body in the form of metabolites, half of them through urine, and thirty percent through feces.

• Duspatalin.

The active substance does not undergo presystemic hydrolysis when taken orally, and does not penetrate into the blood plasma. Metabolism occurs in the liver, where it is converted into veratonic acid and mebeverine alcohol. Metabolites are eliminated from the body by the kidneys, but a small amount of metabolites is removed by bile. The capsules have prolonged release properties. Even repeated administration of the drug does not lead to a significant cumulative effect.

• Imodium Plus.

The half-life is ten hours, although variations can be from nine to fourteen hours in different people. Loperamide hydrochloride has the quality of easy intestinal absorption. Metabolism occurs in the liver, where its conjugation and excretion of metabolites with the help of bile occur. Since the metabolism of the substance is very active, then in the blood there is a fairly low concentration of the component in an unchanged form. Loperamide in the form of metabolites is excreted from the body with feces. Another active component - simethicone does not have the quality of absorption in the gastrointestinal tract.

• Loperamide.

It has intestinal absorption in the amount of forty percent. The active component binds to plasma proteins in the amount of ninety-seven percent. The half-life is considered to be from nine to fourteen hours. Doperamide is not capable of penetrating the blood-brain barrier. The active component, entering the systemic bloodstream, undergoes almost complete metabolism in the liver through conjugation. In the form of metabolites that have undergone conjugation, it is excreted through bile and partially through the kidneys.

• Maalox.

The active ingredients have antacid properties with local action, therefore they are not absorbed and do not have a systemic effect.

• Mezim Forte.

The tablets for stomach pain are covered with an acid-resistant coating that cannot be dissolved by hydrochloric stomach acid. This helps protect the enzymes in the drug from neutralization of their activity. The coating dissolves with subsequent release of enzymes at an acidity level that is neutral or slightly alkaline.

• No-shpa Forte.

The active substance after oral administration exhibits the quality of rapid and complete absorption, then undergoes presystemic metabolism and appears in the systemic bloodstream in the amount of sixty percent of the dose taken. The maximum concentration of the substance in the blood plasma is observed after an interval of forty-five minutes or one hour. The active substance has the ability to bind highly to plasma proteins - from ninety-five percent. The greatest binding occurs with albumins and beta-globulins. The substance is able to evenly distribute itself through tissues and penetrate smooth muscle cells. It is not able to penetrate the blood-brain barrier. In some quantities, the active component or its metabolites can penetrate the placental barrier.

The active component undergoes complete metabolism in the liver via O-deethylation. Its metabolites are capable of rapid conjugation with glucuronic acid.

The half-life of metabolites is sixteen hours. Within seventy-two hours, the drug is completely eliminated from the body. More than half of the metabolites are excreted through the kidneys, thirty percent of the substances - through the gastrointestinal tract by excretion into the bile.

• Festal.

Pancreatin enzymes compensate for the deficiency of enzymes produced by the pancreas. They help improve digestion and absorption of food. In the gastrointestinal tract, a large percentage of pancreatin enzymes are not absorbed. To achieve their effectiveness, absorption is not necessary, and their action occurs in the gastrointestinal tract itself.

Enzymes, moving through the gastrointestinal tract, undergo proteolytic digestion until they are absorbed as converted peptides or amino acids.

The enzymes placed in the core of the pill are protected from digestion in the acidic environment of the stomach by a shell. When they enter the neutral or slightly alkaline environment of the small intestine, the shell dissolves and the enzymes are released. The maximum enzymatic effect occurs after half an hour or forty-five minutes after taking the medicine. Pancreatin enzymes are not able to be absorbed, but are removed from the body with feces in a split or denatured form with the help of food juices or bacteria.

• Phthalazole.

When taken orally, it is slowly absorbed from the gastrointestinal tract. Only five percent of the dose used is observed in the urine. This means that a large amount of the active substance is concentrated in the lumen of the large intestine. There, microorganisms promote the breakdown of phthalazole, from which phthalic acid, an amino group and norsulfazole are formed. The latter substance helps achieve a bacteriostatic effect in relation to pathogens of intestinal diseases: bacillary dysentery, colitis, gastroenterocolitis. The active effect of phthalazole is most observed in the intestinal lumen.

Names of pills for stomach pain

Here are the main names of tablets for abdominal pain that will help you cope with unpleasant sensations in this area.

1. Drotaverine hydrochloride is a synthetic antispasmodic drug that is a derivative of papaverine.
2. Duspatalin is a drug that is a myotropic antispasmodic medicine.
3. Imodium Plus is a combination antidiarrheal drug that suppresses intestinal peristalsis.
4. Loperamide is an antidiarrheal drug.
5. Maalox is a drug that is an antacid medicine.
6. Mezim Forte is a digestive polyenzyme drug.
7. No-shpa Forte is a drug with antispasmodic action.
8. Festal is a digestive medicine that belongs to the group of polyenzyme preparations.
9. Phthalazole is an antimicrobial agent belonging to the group of sulfinamide drugs.

Pills for lower abdominal pain

The causes of lower abdominal pain can be different, so the medications used in this case differ in their spectrum of action. Usually, women experience lower abdominal pain during their period and are an unpleasant side effect of this process. But in some cases, lower abdominal pain in women means the presence of an inflammatory disease of the genitourinary system - ovaries, bladder, and so on. In this case, you should not self-medicate, but seek help from specialists. In men, lower abdominal pain can also mean problems with the genitourinary system, and in this case, you should not self-medicate, but seek advice from a doctor.

Sometimes pain in this area suggests intestinal problems, and in some cases – the presence of an oncological process in one of the organs located in the lower abdomen.

Therefore, if the diagnosis is not established, the pills listed in the previous section will help to get rid of the pain in the lower abdomen. This can be a one-time action that helps to relieve the patient of unpleasant and debilitating symptoms. In the future, you should definitely contact specialists for diagnostics, a correctly established diagnosis and appropriate therapy.

Method of administration and dosage

Each drug comes with instructions that describe in detail the method of use and dosage of each medicine.

• Drotaverine hydrochloride.

It is taken orally. Adults use one or two tablets of the medicine three times a day. Children take a single dose of ten to twenty milligrams of the medicine (from a quarter to half a tablet), the maximum daily dose at this age can be one hundred and twenty milligrams of the drug. Children aged six to twelve years can take a single dose of twenty milligrams (half a tablet) with a maximum dose of two hundred milligrams. Use of the medicine for children is two or three times a day.

• Duspatalin.

The medication is intended for oral use. It is used twenty minutes before meals, without chewing and washed down with water. A single dose is two hundred milligrams, the medicine should be taken in a single dose twice a day, in the morning and evening.

Imodium Plus.

Children over twelve years of age and adults take two tablets of the drug as an initial dose. Subsequently, a single dose is one tablet of the drug taken after each case of loose stool. Up to four tablets of the drug are allowed to be used per day. The course of treatment should not be longer than two days.

• Loperamide.

Tablets for abdominal pain are taken orally and are not chewed, they are washed down with a sufficient amount of water. Adults with acute and chronic manifestations of diarrhea take two capsules of the drug (four milligrams) for the first time. After that, one capsule (two milligrams) of the drug is used, which are taken each time after bowel movement, if there is loose stool. The maximum daily use of the drug is eight capsules.

Children over six years of age use one capsule of the drug after each bowel movement if there is loose stool in acute diarrhea. The maximum amount of the drug that can be taken by children per day is three capsules.

The course of therapy with the drug is determined from seven to twenty days. When the stool has returned to normal or its absence is observed for more than twelve hours, the treatment with the drug must be stopped.

• Maalox.

Tablets for abdominal pain are used orally and should be thoroughly sucked or chewed.

Adults and adolescents over fifteen years of age take one or two tablets three to four times a day, one or two hours after meals and before bedtime.

In case of reflux esophagitis, it is recommended to take the medicine a short time after eating.

The maximum number of times the medication is taken is six times a day. You cannot use more than twelve tablets a day. The course of therapy is from two to three months.

Occasional use of the drug when abdominal discomfort occurs allows one or two tablets of the medication to be taken at a time.

• Mezim Forte.

The tablets are taken orally, without chewing and washed down with plenty of water. The dosage of the medication should be determined individually, which is influenced by the degree of manifestation of the disease and the composition of the food consumed by the patient.

The average single dose is two to four tablets per meal. It is recommended to use half or a third of the single dose at the beginning of the meal, and the remaining amount during the meal.

Sometimes it is possible to increase the single dose, but this only happens on the prescription of a specialist and under his supervision. Such a change in dosage is caused by the patient's symptoms, such as abdominal pain or steatorrhea. The maximum amount of the drug per day is from fifteen to twenty thousand units of lipase per kilogram of the patient's weight.

Children take the medicine in the dosage prescribed by the doctor. In this case, the specialist is guided by the expressed symptoms of the disease and the composition of the food taken by the child. In this case, the amount of the drug should not exceed five hundred to a thousand units of lipase for each kilogram of the sick child's weight at each meal.

The course of treatment lasts from several days to several months or years. The drug is taken for several days in case of digestive disorders and any errors in nutrition. The drug is used for several months or years if constant replacement therapy is required.

• No-shpa Forte.

Tablets for abdominal pain are taken orally. For adults, the daily dosage is from one hundred twenty to two hundred forty milligrams of the drug. The daily dose should be divided into two or three doses. The maximum single dose of the drug is eighty milligrams. The maximum daily dose is two hundred forty milligrams.

For pediatric patients aged six to twelve years, the drug is prescribed in a maximum daily dosage of eighty milligrams, which should be divided into two doses.

For children over twelve years of age, the maximum daily amount is one hundred sixty milligrams, which should be divided into two to four servings.

The course of treatment without consulting a specialist is one or two days. If during this time there is no reduction in pain, it is necessary to consult a doctor to establish the correct diagnosis and prescribe the correct method of treatment. If the drug is used as an element of adjuvant therapy, then the course of self-treatment without consulting a specialist can be two or three days.

• Festal.

The medicine is intended for internal use. It is taken during or immediately after meals, and the medicine should be washed down with water.

Adults take one or two pills three times a day. The children's dose is selected individually by a specialist.

The course of treatment depends on the patient’s problem and can last from several days to several months or years.

• Phthalazole.

Adults take one or two tablets with a break of four to six hours. In the following two or three days, it is recommended to use half the dosage of the drug.

Children can use a dose of one hundred milligrams per kilogram of the child's weight per day. This portion is divided into equal parts and taken every four hours, excluding night sleep. Then two hundred to five hundred milligrams of the drug are used at intervals of six to eight hours.

[ 5 ], [ 6 ], [ 7 ]

Using Stomach Pain Pills During Pregnancy

Most medications are contraindicated for use during pregnancy and breastfeeding. To make sure that you can use any medication, you need to carefully read the instructions, namely, the section that describes the use of tablets for abdominal pain during pregnancy.

• Drotaverine hydrochloride.

The use of the drug during pregnancy does not have teratogenic and embryotoxic effects. However, the drug should be used with caution during this period.

There is no data on the effect of drotaverine hydrochloride on milk during lactation. Therefore, it should not be used during breastfeeding.

• Duspatalin.

Animal experiments have not revealed any teratogenic effect of the active substance. The drug may be prescribed during pregnancy based on the benefit to the mother and the potential risk to the fetus.

The medication can be used during lactation, since the active component is not found in therapeutic doses in breast milk.

• Imodium Plus.

In modern medicine there is no data on the teratogenic and embryotoxic effects of the active components of the drug. The drug is approved for use during pregnancy, and especially during the first trimester, only if there are significant indications for the woman.

There is insufficient information on the excretion of active components in breast milk. Some amount of the drug was found in breast milk, so taking the medication during lactation is not recommended.

• Loperamide.

These stomach pain pills are not used in the first trimester of pregnancy. In the second and third trimesters, the medication can be prescribed only if the high benefit to the mother is compared with the low potential risk to the fetus.

Not used during lactation.

• Maalox.

At this point in time, there is no information on the presence of teratogenic effects when taking pills during pregnancy. But the limited clinical experience of studying the drug gives permission for its use only if there is a clear benefit to the mother, which explains the possible risk to the fetus.

Large doses are not recommended during pregnancy, and the drug should not be used for a long period of time.

If the indicated amounts of the drug are used by nursing mothers, this results in limited absorption of active substances into the female body, which is compatible with breastfeeding.

• Mezim Forte.

There is no sufficient data on the effect of the drug on the course of pregnancy in women and the fetus. Therefore, it can only be used if the specialist is confident in the benefits of the drug for the mother and the low risk to the fetus. The same applies to the lactation period, since there is no information on the penetration of the active components of the drug into breast milk.

• No-shpa Forte.

Animal studies have not revealed any teratogenic or embiogenic effects of the active component of the drug. However, the medication should be taken during pregnancy only if the potential benefit to the mother and low risk to the fetus are taken into account.

There is no data on the penetration of the drug into breast milk, therefore, it should not be prescribed during lactation.

• Festal.

The drug can be used during pregnancy or lactation only for acute indications, when its use provides significant benefits to the mother.

• Phthalazole.

The drug has good penetration through the placental barrier and is found in breast milk. Therefore, its use is possible only when the potential risk to the fetus is minimal and the benefit to the mother is maximum.

Contraindications to the use of tablets for abdominal pain

There are cases when the drug cannot be used to relieve pain. These may be diseases or certain conditions of the patient, in which another drug must be selected. Contraindications to the use of tablets for abdominal pain are described in the instructions, which must be read before using the medication.

1. Drotaverine hydrochloride.
   • The presence of hypersensitivity to the active component of the drug or to any excipient.
   • Existing signs of severe liver and kidney failure.
   • History of severe heart failure, low cardiac output syndrome.
   • The patient's age is under one year.
2. Duspatalin.
   • Existing high sensitivity to the active substance or auxiliary components of the drug.
   • Children's age of patients under eighteen years.
3. Imodium Plus.
   • Having high sensitivity to one or more components of the drug.
   • The presence of acute ulcerative colitis or pseudomembranous colitis, which are associated with therapy with broad-spectrum antibacterial drugs.
   • It is prohibited to use the drug as monotherapy for the treatment of acute dysentery, which is characterized by bloody stools or high fever.
   • Tablets for abdominal pain are not prescribed to patients under twelve years of age.
4. Loperamide.
   • History of hypersensitivity to the components of the drug.
   • History of lactose intolerance.
   • The presence of lactase deficiency or confirmation of glucose-galactose malabsorption.
   • The appearance of symptoms of diverticulosis, intestinal obstruction, ulcerative colitis during an exacerbation, as well as signs of diarrhea caused by pseudomembranous enterocolitis.
   • Also, the drug cannot be used as monotherapy for dysentery and other infectious diseases of the gastrointestinal tract.
   • Tablets for abdominal pain are prohibited for use by pediatric patients under six years of age.
5. Maalox.
   • The presence of severe renal failure.
   • The occurrence of hypersensitivity to the active or auxiliary substances of the drug.
   • The patient has hypophosphatemia.
   • The development of fructose intolerance.
   • The patient's age is up to fifteen years.
   • Also additionally for chewable tablets with sugar:
   • History of glucose-galactose malabsorption syndrome.
   • The appearance of sucrase-isomaltase deficiency.
   • For sugar-free chewable tablets:
   • Existing signs of maltitol intolerance.
6. Mezim Forte.
   • The presence of hypersensitivity to pancreatin or other substances of the drug.
   • History of signs of acute pancreatitis.
   • Presence of exacerbation of chronic pancreatitis.
   • Hereditary factors that cause lactase intolerance.
   • Hereditary occurrence of glucose-galactose malabsorption syndrome.
   • The age of patients is up to three years.
7. No-shpa Forte.
   • The presence of high sensitivity to the active component of the drug or excipients.
   • Existing symptoms of severe liver or kidney failure.
   • The presence of severe heart failure and low cardiac output syndrome.
   • The patient's age is under six years.
   • The presence of hereditary galactose intolerance, as well as signs of hereditary lactase deficiency and glucose-galactose malabsorption syndrome.
   • It should be used with caution in patients with arterial hypertension, as well as in patients aged six to eighteen years.
   • The presence of exacerbated erosive and ulcerative diseases of the gastrointestinal tract, for example, gastric ulcer and duodenal ulcer, Crohn's disease, nonspecific ulcerative colitis.
   • The presence of hemophilia and other diseases indicating problems with blood clotting, including hypocoagulation, as well as the appearance of hemorrhagic diathesis.
   • The patient's medical history of the period following coronary artery bypass grafting.
   • The occurrence of bleeding from the gastrointestinal tract, as well as the appearance of intracranial hemorrhages.
   • The presence of severe liver failure or any other liver diseases in the active stage.
   • The presence of severe renal failure.
   • The patient has a history of confirmed hyperkalemia.
   • The patient's age is under twelve years.
8. Festal.
   • The presence of high sensitivity to one of the components of the drug.
   • The occurrence of acute pancreatitis.
   • The presence of an exacerbation of chronic pancreatitis.
   • The occurrence of liver failure.
   • The appearance of hepatitis.
   • Presence of mechanical jaundice.
   • The occurrence of gallstone disease.
   • The appearance of empyema of the gallbladder.
   • The occurrence of intestinal obstruction.
   • The patient's age is under six years.
9. Phthalazole.
   • The presence of hypersensitivity to drugs from the sulfonamide group.
   • History of blood diseases.
   • Presence of hyperthyroidism.
   • The development of chronic renal failure.
   • The appearance of glomerulonephritis.
   • Presence of acute hepatitis.
   • The occurrence of intestinal obstruction.
   • The patient's age is up to three years.
   • Presence of lactase deficiency.
   • The occurrence of lactose intolerance, as well as glucose-galactose malabsorption.
   • Should be used with caution in cases of nephritis.

[ 3 ], [ 4 ]

Side effects of stomach pain pills

Almost all medications are characterized by the occurrence of undesirable effects after their use. Side effects of pills for abdominal pain can be different, depending on the active substances of the drugs.

Drotaverine hydrochloride.

• Gastrointestinal tract: occurrence of constipation and nausea.
• Nervous system: occurrence of headaches, dizziness, insomnia.
• Cardiovascular system: occurrence of increased heart rate and hypotension.

Duspatalin.

• These tablets for abdominal pain are well tolerated.
• In some cases, allergic reactions may occur.
• Nausea, headache and dizziness may also occur.

Imodium Plus.

• There are no signs of serious side effects from even long-term use of loperamide.
• In some cases, a hypersensitivity reaction to the components of the drug may appear in the form of skin reactions; there are reports of isolated cases of anaphylactic shock and bullous rashes, which even looked like toxic epidermal necrolysis.
• In the event of side effects, the cause of their occurrence was the simultaneous use of certain drugs that led to the occurrence of allergic reactions.
• Sometimes constipation occurs with parallel bloating.
• In very rare cases, paralytic intestinal obstruction may occur. But even in such patients, such an effect occurred only when the doctor's recommendations were violated.
• Rarely, signs of abdominal pain or discomfort, nausea and vomiting, extreme fatigue, drowsiness, dizziness and dry mouth may occur.

Loperamide.

• The appearance of symptoms of abdominal discomfort, flatulence, gastralgia, intestinal colic, constipation, intestinal obstruction.
• The occurrence of dryness in the oral cavity.
• The appearance of allergic reactions in the form of skin rashes and hives.
• The occurrence of nausea and vomiting.
• The appearance of headaches, dizziness, drowsiness or signs of insomnia.
• The occurrence of urinary retention.

Maalox.

• If you follow the recommendations of specialists, the occurrence of side effects may be in small quantities.
• Immune system – the appearance of hypersensitivity to the components of the drug, which is expressed as itching, urticaria, angioedema and anaphylactic reactions.
• Gastrointestinal tract – the appearance of diarrhea or constipation.
• Metabolic processes – the appearance of hypermagnesemia, hyperaluminemia, hypophosphatemia, which leads to increased bone tissue resorption. Such side effects occur if the duration of the course of treatment or the dosage of tablets for abdominal pain is violated. Signs of hypercalciuria and osteomalacia may also be observed.

Mezim Forte.

• There is no evidence of side effects or any complications in medical practice. Even long-term and regular use of tablets for abdominal pain in patients with pancreatic problems did not result in side effects.
• In some cases, allergic reactions may occur.
• Rarely, cases of diarrhea or constipation, nausea, and discomfort in the epigastric region are detected.
• Patients with a history of cystic fibrosis may experience hyperuricosuria, which is characterized by elevated levels of uric acid in the blood serum. This only occurs with prolonged use of the drug at high dosages.
• Occasionally, patients with cystic fibrosis may develop strictures in the ileocecal region and ascending colon.

No-shpa Forte.

• Cardiovascular system – in rare cases, symptoms of increased heart rate and low blood pressure appear.
• Central nervous system – the appearance of headaches, dizziness and insomnia.
• Gastrointestinal tract - in rare cases, symptoms of nausea and constipation may occur.
• Immune system – rare patients may experience allergic reactions, namely angioedema, urticaria, rash, itching.

Festal.

• Digestive system – the appearance of nausea, diarrhea, abdominal pain, decreased production of endogenous bile acids.
• Allergic reactions – hives, itchy skin.

Phthalazole.

• Digestive system – the appearance of nausea, vomiting, diarrhea, lesions of the oral cavity in the form of stomatitis, gingivitis, glossitis, the occurrence of gastritis, cholangitis, hepatitis, deficiency of B vitamins, which is a consequence of the suppression of intestinal microflora.
• Blood system – symptoms of leukopenia, thrombocytopenia, agranulocytosis, erythrocyte hemolysis may rarely appear. Long-term use of the drug leads to the formation of anemia, which is a consequence of the low content of pantothenic and pteroinglutaric acids, which are produced by microorganisms.
• Cardiovascular system – the appearance of myocarditis and cyanosis.
• Nervous system – occurrence of headaches, dizziness, depressed mood.
• Respiratory system – the appearance of eosinophilic pneumonia.
• Urinary system – occurrence of urolithiasis.
• Allergic reactions and manifestations of toxic-allergic nature - the appearance of drug allergy, which manifests itself in the form of skin rashes that can even be similar to nodular or multiform erythema. In some cases, the appearance of epidermal necrolysis is observed. Sometimes there are symptoms of allergic edema of the lips and face, as well as nodular periarteritis.

Overdose

Overdose usually occurs when the specialist's recommendations or the method of administration described in the instructions were violated. This happens when the patient begins to independently take large doses of the drug or uses it for a long time.

Drotaverine hydrochloride.

• There are no data on cases of overdose.

Duspatalin.

• In case of overdose, symptoms of central nervous system overexcitation may occur.
• In such cases, it is recommended to wash out the stomach, take activated charcoal or another sorbent, and also apply symptomatic treatment.
• There is no specific antidote to the drug.

Imodium Plus.

• Overdose causes liver dysfunction, which affects the central nervous system. Symptoms of stupor, coordination disorder, drowsiness, miosis, muscle hypertonus, and respiratory inhibition appear. Childhood patients experience symptoms of central nervous system inhibition more frequently than adults.
• Signs of paralytic ileus are also observed.
• Before overdose symptoms appear, the patient should be given an antidote such as Naloxone. Imodium Plus has a longer duration of action than Naloxone, so it is possible to administer a second dose of the antidote.
• To establish the effectiveness of antilot therapy, which consists of the absence of signs of inhibition of the central nervous system, the patient should be under the supervision of specialists for two days.

Loperamide.

• The appearance of signs of central nervous system depression in the form of stupor, impaired coordination, drowsiness, miosis, muscle hypertension, and respiratory depression.
• Signs of intestinal obstruction may also be observed.
• In these cases, it is necessary to resort to the use of an antidote - Naloxone.
• Loperamide has a much longer lasting effect than Naloxone, so repeated administration of the antidote will be required.
• Symptomatic therapy in the form of activated charcoal, gastric lavage, and artificial ventilation of the lungs can also be used.
• If symptoms of an overdose occur, the patient needs to be monitored by specialists in a hospital setting for two days.

Maalox.

• The appearance of diarrhea, abdominal pain and vomiting.
• Patients at risk may experience new or worsening bowel obstruction or ileus. These patients include those with renal failure, patients with a history of porphyria, patients undergoing hemodialysis, patients with Alzheimer's disease, diabetes, and the elderly.
• If symptoms of overdose occur, it is recommended to use large amounts of fluid to force diuresis. This is necessary because aluminum and magnesium preparations are excreted from the body through urine. Patients with renal failure should undergo hemodialysis or peritoneal dialysis.

Mezim Forte.

• There are no data on drug overdose or cases of intoxication.
• Some patients may experience symptoms of hyperuricosuria and hyperucemia.
• Constipation may occur in pediatric patients.
• If undesirable symptoms occur, the drug should be discontinued and symptomatic therapy should be prescribed.

No-shpa Forte.

• A disturbance in the heart rhythm and cardiac conduction, which can even lead to complete bundle branch block and cardiac arrest, which in some cases can be fatal.
• In case of overdose, the patient should be hospitalized under the supervision of specialists. If necessary, symptomatic and supportive therapy is prescribed, which also includes procedures for inducing vomiting reflexes and gastric lavage.

Festal.

• If stomach pain pills are used for a long time and in high dosages, this can lead to an increase in the level of uric acid in the blood plasma and urine.
• When using high doses of the medication, children experience skin irritation, which affects the perinatal area and the oral mucosa.
• In case of overdose, symptomatic therapy is indicated.

Phthalazole.

• In this case, signs of pancytopenia appear, in which the number of all blood cells decreases sharply.
• Sometimes nausea, vomiting and headache occur.
• In these cases, the drug is discontinued and symptomatic treatment is prescribed if necessary.

Interactions of stomach pain pills with other drugs

It happens that when taking different medications at the same time, undesirable effects occur. Therefore, it is very important to read the section on the interaction of tablets for abdominal pain with other drugs and exclude unnecessary combinations.

• Drotaverine hydrochloride.

The simultaneous use of levodopa and drotaverine hydrochloride leads to a weakening of the antiparkinsonian effect of the first substance.

• Duspatalin.

No interactions of the drug with other drugs have been identified. Therefore, the medication can be used in combination with any medication.

• Imodium Plus.

Interactions were noted only with drugs with similar antidiarrheal effects. No other drug interactions were observed.

• Loperamide.

Concomitant use of abdominal pain tablets and opioid analgesics or Cholestyramine may result in severe constipation. Concomitant use of Co-trimoxazole, Ritonavir increases the bioavailability of the active component of the drug, which causes inhibition of its metabolism processes during its first passage through the liver.

• Maalox.

If it is used together with quinidine, an increase in the concentration of quinidine in the blood serum and the occurrence of quinidine overdose are observed.

With the simultaneous use of histamine receptor blockers, propranolol, atenolol, cefpodoxime, metoprolol, chloroquinine, prostacyclin, diflunisalone, digoxin, bisphosphonates, ethambatol, isoniazid, fluoroquinolones, sodium fluoride, prednisolone, dexamethone, indomethacin, ketoconazole, lincosamides, phenothiazine neuroleptics, penicillamine, rosuvastatin, iron salts, levothyroxine and the drug, a decrease in the absorption of the above drugs in the gastrointestinal tract is observed. If there is a two-hour interval between taking these medications and Maalox and a four-hour interval between taking fluoroquinolones and Maalox, then no adverse effect of the drug is observed.

When polystyrene sulfonate (kayexalate) and the drug are used simultaneously, caution is required due to the possibility of low potassium binding by the resin and the development of symptoms of metabolic alkalosis in patients with renal failure, as well as the development of intestinal obstruction.

When used simultaneously with citrates, an increase in the concentration of aluminum in the blood serum is observed, especially in those patients who suffer from renal failure.

• Mezim Forte.

Tablets for abdominal pain that contain pancreatin and Mezim Forte when taken simultaneously reduce the absorption of folic acid. Hypoglycemic drugs such as Acarbose and Miglitol reduce their effectiveness if taken together with pancreatin, which is part of the medication.

The combined use of the drug and iron preparations leads to a possible decrease in the level of absorption of drugs that include iron.

When used simultaneously with antacids containing calcium carbonate or magnesium hydroxide, the quality of action of Mezim Forte decreases.

• No-shpa Forte.

The combined use of levodopa and No-shpa leads to a decrease in the antiparkinsonian effect of the first drug. At the same time, rigidity and tremor, characteristic of the disease, increase.

Other antispasmodic drugs, for example, those containing m-anticholinergics, lead to an increase in the antispasmodic effect.

Interaction with drugs that have a high binding quality with blood plasma proteins (more than eighty percent): there is no data on it. Although there is an assumption about the possibility of their interaction with drotaverine, which is manifested at the level of their connections with plasma proteins. This can cause certain pharmacodynamic or toxic side effects of No-shpa.

• Festal.

Simultaneous use leads to increased absorption of drugs that contain para-aminosalicylic acid. Sulfonamides and antibacterial drugs experience the same effect.

Concomitant use may result in decreased absorption of iron-containing drugs.

Concomitant use with antacid medications that contain calcium carbonate or magnesium hydroxide leads to a decrease in the effectiveness of Festal.

• Phthalazole.

It is allowed to be used simultaneously with antibacterial medications from different groups, which leads to an increase in the antimicrobial effect.

Sulfanilamide drugs taken simultaneously with the medicine lead to an increase in its effect and expansion of the spectrum of action. It is allowed to use the medicine and sulfonamides, which are characterized by good absorption into the blood. This applies to Biseptol, Etazol, Etazol-sodium, Sulfadimezine.

It is prohibited to use together with some medicines, namely with PAS derivatives - Novocaine, Anestezin, Dicaine; barbiturates - Pentobarbital, Phenobarbital, Penobarbital and so on; salicylates - Aspirin, Aspirin-Cardio; Diphenyl; Oxacillin; nitrofurans - Furazolidone and others; hormonal drugs and oral contraceptives; Calcium chloride, vitamin K, Thiocetasone, Levomycetin, hexamethylenetramine, Adrenaline; indirect anticoagulants - Warfarin, Thrombostop and others.

It is prohibited to use the drug and enterosorbents, as well as laxatives. Enterosorbents can be taken only an hour after using the medication.

Storage conditions for tablets for abdominal pain

Each drug requires special characteristics for its content. Proper storage conditions for stomach pain pills allow the drug to be used effectively throughout its shelf life.

1. Drotaverine hydrochloride - the drug must be stored in a place protected from moisture and light, as well as from children, at a temperature not exceeding twenty-five degrees Celsius.
2. Duspatalin - the medicine must be kept out of reach of children, in a dry place at a temperature of five to thirty degrees Celsius.
3. Imodium Plus - the drug should be stored in a place inaccessible to children, at a temperature of fifteen to thirty degrees Celsius.
4. Loperamide - the drug must be kept in a dry room, protected from sunlight and children, at a temperature not exceeding twenty-five degrees Celsius.
5. Maalox - the drug is stored out of the reach of children and at a temperature not exceeding twenty-five degrees Celsius.
6. Mezim Forte - the medicine is kept in a dry and dark place, out of reach of children, at a temperature of up to twenty-five degrees Celsius.
7. No-shpa Forte - the medicine is stored at an ambient temperature of up to twenty-five degrees Celsius, in a place where children cannot reach.
8. Festal - is kept at a temperature of up to twenty-five degrees Celsius in a place where moisture and children's faces do not penetrate.
9. Phthalazole - placed in a place inaccessible to children, protected from moisture and sunlight, at a temperature of up to twenty degrees Celsius.

Best before date

The expiration date of each drug is indicated on the cardboard box or other packaging of the drug.

1. Drotaverine hydrochloride – two years from the date of manufacture.
2. Duspatalin – thirty-six months from the date of manufacture.
3. Imodium Plus – two years from date of manufacture.
4. Loperamide – thirty-six months from date of manufacture.
5. Maalox – five years from date of manufacture.
6. Mezim Forte – three years from the date of production.
7. No-shpa Forte – five years from the date of production.
8. Festal – thirty-six months from the date of production.
9. Phthalazole – four years from date of manufacture.

Tablets for stomach pain are not a panacea, but a first aid measure in cases where self-medication is possible. And even when the patient knows the problem, it is best not to engage in self-therapy, but to seek help from specialists.